CLL patients in England to get AZ's Calquence after okay from NICE NHS England is to grant immediate access to AstraZeneca’s cancer drug Calquence (acalabrutinib) for certain patients with chronic ...

Roche/AbbVie’s cancer drug venetoclax, which is set to become standard of care in chronic lympocytic leukaemia, could further improve prognosis earlier in the disease according to a UK expert.

Abstract: Optimization is the process of searching optimal solution of complex problems more efficiently. There is a class of problems which is called NP (nondeterministic polynomial) problem which ...